Long-term antibody responses to COVAXIN and COVISHIELD vaccines in rheumatoid arthritis patients and healthy control population – A cross-sectional study by Vijaya Prasanna Parimi, Anand Pyati, Madhavi Eerike

Subjects: Get full text

Insight into the Advances in Clinical Trials of SARS-CoV-2 Vaccines by Syed Mohammed Basheeruddin Asdaq, Shahamah Jomah, Syed Imam Rabbani, Ali Musharraf Alamri, Salman Khalaf Salem Alshammari, Badr Sami Duwaidi, Majed Sadun Alshammari, Abdulhakeem S. Alamri, Walaa F. Alsanie, Majid Alhomrani, Nagaraja Sreeharsha, Mohd. Imran

“…Among them are BioNTech and Moderna vaccines (mRNA based); ChAdOx1, Gam-COVID-Vac, Janssen vaccines (vector-based); CoronaVac, COVAXIN (virus inactivated); and EpiVacCorona vaccine (viral peptide). …”
Get full text

A Cross-Sectional Study on Side Effects of “Corbevax” Covid-19 Vaccine among 12- to 14-Year Age Group in a Tertiary Care Hospital in Meerut, Uttar Pradesh by Chhaya Mittal, Harimu Bargayary, Mohit Saini

“…Background: The first mass vaccination program for COVID-19 in India started on January 16, 2021. Initially, Covaxin and Covishield were used. Later, the Government of India has approved the usage of Corbevax, a Hyderabad-based biological E SARS-CoV-2 (COVID-19) vaccine among 12- to 14-year age group from March 16, 2022. …”
Get full text

Papel del Estado en la campaña de vacunación contra la COVID-19 a través del ordenamiento jurídico by Rodolfo Arevalo Marcos, Yolanda Maria Siguas Astorga, Marcos Antonio Montoro Valdivia, José Luis Salazar Huarote

“…Durante el proceso de emergencia, las vacunas que aprobaron las autoridades para la población fueron las Pfizer-BioNTech, Moderna, Sputnik, Jhonson & Jhonson, AstraZeneca, Sinopharm, Sinovac, Covaxin y Covocax. El papel del Estado durante la pandemia ha sido de vital importancia y tiene como objetivo ofrecer respuestas eficaces a la salud pública, con aciertos y desaciertos el Estado debe efectivizar los derechos sociales, culturales y económicos. …”
Get full text